Vermilion Macro Vision: Health Care Sector Synopsis
Health Care Sector: Market Weight. Health Care's technical appeal continues to grow. Since bottoming (from a relative strength perspective) in January, the Sector has staged a technical recovery, with over half of our Health Care Groups now ranking in the top-third of the market (i.e. RSR “1-10â€). Groups leading this recovery range from Medical Supplies/Devices to Cardiovascular Products to HMOs. Within med devices, breakouts and bullish breakouts are visible in ABT, JNJ, BDX, GRFS, ATRI, and IVC. Cardio Products, a Group whose RS trend is rebounding off long-term support, contains opportunities in names like: MDT, ABMD, and MMSI. Also, base breakouts are prevalent in our Surgical Devices & Equipment Group, including CNMD and ATRC. Lastly, benefitting from the House's vote to repeal the ACA, HMSs are breaking out from multi-year base patterns: AET, ANTM, CI, and HUM.See attachment for complete synopsis.
For a trial to Vermilion Technical Research call (952) 922-7500, or visit our website at: www.vermilioncap.com
Vermilion Research delivers timely, actionable, and unique research inputs to professional investors. Our research strategists highlight securities which we believe are at major inflection points, based on our various proprietary technical indicators, and offer asymmetric risk/return profiles. We believe our research methodology, which is not limited by industry sector or market capitalization, enables us to deliver superior investment recommendations.
Our process begins by organizing all actively traded stocks into coherent sectors, then into logical industry groups. We then apply our proprietary relative strength tools to identify developing price trends. Once attractive trends are identified within a selected sectors or groups, we screen for individual stocks which we believe offer the best risk/reward profile. Vermilion offers U.S. and global equity market research products. Vermilion’s research team, which has received numerous awards and accolades, has a combined 70 year of experience in the analysis of investment securities.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.